Hayes, E, Gubler, D. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annual Review of Medicine
2006; 57: 181–194.
Beasley, DWC, Barrett, ADT. Virulence of West Nile virus in different animal hosts. In Diamond, MS, ed.
West Nile Encephalitis Virus Infection
. New York: Springer, 2009, pp. 137–153.
Petersen, L, Marfin, A, Gubler, D. West Nile virus. Journal of the American Medical Association
2003; 290: 524.
Fonseca, K, et al.
West Nile virus infection and conjunctival exposure. Emerging Infectious Diseases
2005: 11: 1648–1649.
Gyure, K. West Nile virus infections. Journal of Neuropathology & Experimental Neurology
2009; 68: 1053.
Nash, D, et al.
The outbreak of West Nile virus infection in the New York City area in 1999. New England Journal of Medicine
2001; 344: 1807.
Giladi, M, et al.
West Nile encephalitis in Israel, 1999: the New York connection. Emerging Infectious Diseases
2001; 7: 659.
Lanciotti, R, et al.
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science
1999; 286: 2333.
Saidi, S. Viral antibodies in preschool children from the Caspian area, Iran. Iranian Journal of Public Health
1974; 3: 83–91.
Saidi, S, et al.
The prevalence of human infection with West Nile in Iran. Iranian Journal of Public Health
1974; 5: 8–14.
Huhn, G, Dworkin, M. Rash as a prognostic factor in West Nile virus disease. Clinical Infectious Diseases
2006; 43: 388–389.
Asnis, D, et al.
The West Nile virus outbreak of 1999 in New York: the Flushing hospital experience. Clinical Infectious Diseases
2000; 30: 413–418.
Chowers, M, et al.
Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerging Infectious Diseases
2001; 7: 675.
Ergünay, K, et al.
West Nile virus seroprevalence in blood donors from central Anatolia, Turkey. Vector-Borne and Zoonotic Diseases
2009; 10: 199–202.
Zeller, H, Schuffenecker, I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. European Journal of Clinical Microbiology & Infectious Diseases
2004; 23: 147–156.
Hamdan, A, et al.
Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transplant Infectious Disease
2002; 4: 160–162.
Mostashari, F, et al.
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet
2001; 358: 261–264.
O'Leary, D, et al.
The epidemic of West Nile virus in the United States, 2002. Vector-Borne and Zoonotic Diseases
2004; 4: 61–70.
Corrigan, R, et al.
Prediction of human cases of West Nile virus by equine cases, Saskatchewan, Canada, 2003. Preventive Veterinary Medicine
2006; 76: 263–272.
Tilley, P, et al.
Screening of organ and tissue donors for West Nile virus by nucleic acid amplification – a three year experience in Alberta. American Journal of Transplantation
2008; 8: 2119–2125.
Petersen, L, Roehrig, J. West Nile virus: a reemerging global pathogen. Emerging Infectious Diseases
2001; 7: 611–614.
Klee, A, et al.
Long-term prognosis for clinical West Nile virus infection. Emerging Infectious Diseases
2004; 10: 1405–1411.
Tsai, T, et al.
West Nile encephalitis epidemic in southeastern Romania. Lancet
1998; 352: 767–771.
Hubalek, Z, Halouzka, J. West Nile fever – a reemerging mosquito-borne viral disease in Europe. Emerging Infectious Diseases
1999; 5: 643.